ATLAS / Macro Radar / Reporting / CLDX

Celldex Therapeutics, Inc. (CLDX) reporting calendar

Celldex Therapeutics, Inc. files periodic reports with the SEC as CLDX on Nasdaq. Atlas tracks 75 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
28 Jul 2026 – 17 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
75

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open CLDX market profile Latest filing on SEC EDGAR ↗ All Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001104659-26-057113
10-K31 Dec 202525 Feb 202656 days0001104659-26-019652
10-Q30 Sep 202510 Nov 202541 days0001104659-25-109137
10-Q30 Jun 20257 Aug 202538 days0001410578-25-001610
10-Q31 Mar 20258 May 202538 days0001410578-25-001111
10-K31 Dec 202427 Feb 202558 days0001410578-25-000216
10-Q30 Sep 20246 Nov 202437 days0001410578-24-001766
10-Q30 Jun 20248 Aug 202439 days0001410578-24-001219
10-Q31 Mar 20246 May 202436 days0001410578-24-000593
10-K31 Dec 202326 Feb 202457 days0001410578-24-000076
10-Q30 Sep 20232 Nov 202333 days0001410578-23-002169
10-Q30 Jun 20238 Aug 202339 days0001410578-23-001588
10-Q31 Mar 20234 May 202334 days0001104659-23-055992
10-K31 Dec 202228 Feb 202359 days0001104659-23-026701
10-Q30 Sep 20229 Nov 202240 days0001104659-22-116466
10-Q30 Jun 20228 Aug 202239 days0001104659-22-087222
10-Q31 Mar 20225 May 202235 days0001104659-22-056442
10-K31 Dec 202128 Feb 202259 days0001104659-22-028070
10-Q30 Sep 20219 Nov 202140 days0001104659-21-136268
10-Q30 Jun 20215 Aug 202136 days0001104659-21-100745
10-Q31 Mar 20216 May 202136 days0001104659-21-062387
10-K31 Dec 202029 Mar 202188 days0001104659-21-043161
10-Q30 Sep 20205 Nov 202036 days0001104659-20-121786
10-Q30 Jun 20206 Aug 202037 days0001104659-20-091459
10-Q31 Mar 20206 May 202036 days0001104659-20-057436
10-K31 Dec 201926 Mar 202086 days0001047469-20-001809
10-Q30 Sep 201912 Nov 201943 days0001104659-19-062181
10-Q30 Jun 20197 Aug 201938 days0001104659-19-044531
10-Q31 Mar 20197 May 201937 days0001104659-19-027513
10-K31 Dec 20187 Mar 201966 days0001047469-19-000992
10-Q30 Sep 20187 Nov 201838 days0001104659-18-066648
10-Q30 Jun 20188 Aug 201839 days0001104659-18-050496
10-Q31 Mar 201810 May 201840 days0001104659-18-031972
10-K31 Dec 20177 Mar 201866 days0001047469-18-001363
10-Q30 Sep 20177 Nov 201738 days0001104659-17-066472
10-Q30 Jun 20178 Aug 201739 days0001104659-17-050250
10-Q31 Mar 20179 May 201739 days0001104659-17-031139
10-K31 Dec 201614 Mar 201773 days0001047469-17-001564
10-Q30 Sep 20167 Nov 201638 days0001104659-16-155185
10-Q30 Jun 20168 Aug 201639 days0001104659-16-137913

Source: SEC EDGAR company submissions for CIK 0000744218. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.